Why Is NovoLog Mix 70/30 So Hard to Find? [Explained for 2026]

If you've been standing at a pharmacy counter and hearing "we're out of stock" for NovoLog Mix 70/30, you're not alone. Since 2024, patients across the United States have been struggling to fill prescriptions for this critical premixed insulin. Understanding why the shortage happened — and what's changed in 2026 — can help you plan ahead and protect your health.

What Is NovoLog Mix 70/30?

NovoLog Mix 70/30 is a premixed insulin that combines 70% insulin aspart protamine (intermediate-acting) and 30% insulin aspart (rapid-acting). It starts working within 10 to 20 minutes after injection, peaks around 2 hours, and continues working for up to 24 hours. It is typically injected twice a day — before breakfast and before dinner — to cover both mealtime blood sugar spikes and background insulin needs between meals.

Manufactured by Novo Nordisk and first approved by the FDA in 2001, NovoLog Mix 70/30 is prescribed to adults with type 1 and type 2 diabetes who benefit from a convenient, all-in-one insulin option. For many patients, it's not just a preference — it's a routine that's essential to daily survival.

Why Has NovoLog Mix 70/30 Been Hard to Find?

The shortage has several overlapping causes that built up over 2024 and 2025:

• Manufacturing delays at Novo Nordisk: In early 2024, Novo Nordisk reported that production delays at their manufacturing facility caused a shortage of NovoLog vials. The ASHP (American Society of Health-System Pharmacists) formally added insulin aspart protamine and insulin aspart mix to its shortage list in July 2024.
• Discontinuation of unbranded versions: Novo Nordisk discontinued its unbranded (generic-equivalent) insulin aspart protamine and insulin aspart mix products effective December 31, 2025. This further narrowed supply options for patients who relied on lower-cost alternatives.
• Demand surge from other shortages: When Humalog and other insulin products faced their own supply constraints in 2024, some patients switched to NovoLog Mix 70/30, increasing demand in an already strained supply chain.
• Retail pharmacy distribution gaps: Even when product resumed shipping to wholesalers, the time it takes to "flow downstream" to individual pharmacies means some locations remained out of stock for weeks after supply resumed.

What Changed in 2025 and 2026?

The landscape for insulin aspart products shifted significantly heading into 2026:

• Novo Nordisk announced major list price reductions — up to 75% on some products — effective January 1, 2026.
• NovoLog Mix 70/30 vials are priced at approximately $72.34 per vial and FlexPens at $139.71 after these cuts.
• The branded NovoLog Mix 70/30 FlexPen remains in production, while certain older delivery forms have been discontinued.

Despite these changes, patients are still reporting difficulty finding NovoLog Mix 70/30 at specific pharmacies, particularly large chain stores. Independent and specialty pharmacies often have better stock during shortage periods.

Why Does It Matter So Much If You Can't Find It?

Insulin is not a medication that can simply be skipped. For people with type 1 diabetes, it is life-sustaining. For those with type 2 diabetes, missing doses leads to dangerously elevated blood sugar, potential hospitalization, and long-term complications including nerve damage, kidney disease, and vision loss.

Switching insulin types without medical guidance is also risky. Different insulins have different onset times, peak effects, and durations. Substituting another insulin without your doctor's input can lead to unexpected hypoglycemia or hyperglycemia.

What Should You Do If Your Pharmacy Doesn't Have It?

Here are practical steps to take:

1. Call multiple pharmacies. Don't stop at one. Inventory varies significantly between pharmacies, even within the same chain.
2. Try independent pharmacies. Smaller, independent pharmacies often have more flexible supplier relationships and may have stock when major chains do not.
3. Use medfinder. medfinder calls pharmacies near you to check which ones can fill your NovoLog Mix 70/30 prescription — saving you hours of phone calls.
4. Talk to your doctor. If NovoLog Mix 70/30 truly cannot be found nearby, ask your provider about whether a therapeutic alternative (like Humalog Mix 75/25 or separate basal/bolus insulin) might work for you.
5. Check the Novo Nordisk NovoCare line. Call 1-844-668-6463 for help navigating supply and savings options directly from the manufacturer.

How Does medfinder Help Patients During a Shortage?

During a shortage like this one, the difference between finding your medication and going without often comes down to which pharmacies you call — and how quickly you can reach them. medfinder is a paid service that does that legwork for you: you tell us your medication, dose, and location, and we call pharmacies to find out which ones have it in stock. Results are texted directly to you.

For more on locating NovoLog Mix 70/30 specifically, read our guide: How to Find NovoLog Mix 70/30 In Stock Near You (Tools + Tips).

The Bottom Line

NovoLog Mix 70/30 has been hard to find due to a combination of manufacturing delays, product discontinuations, and distribution lag — all happening at the same time. The situation is improving in some areas but remains unpredictable at the pharmacy level. Being proactive, knowing your options, and having a plan before you run out are the best defenses. Do not wait until your last pen or vial to start looking.